Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New markers for cancer detection.

Ivy H N Wong1, Y M Dennis Lo

  • 1Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., Hong Kong Special Administrative Region.

Current Oncology Reports
|October 2, 2002
PubMed
Summary

Detecting cancer early is crucial. Blood tests analyzing DNA methylation and mRNA markers show promise for early cancer detection and monitoring treatment effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequencing of Pleural Fluid and Plasma for Tuberculous Pleuritis.

NEJM evidence·2026
Same author

Holistic determination of ends of cfDNA molecules.

Cell genomics·2026
Same author

Checking Up on the King of Cancers.

Cancer discovery·2026
Same author

Cell-free DNA in 2030.

Med (New York, N.Y.)·2026
Same author

Clinical Variables and Cell-Free DNA Fragmentomics: Biological and Clinical Insights.

Clinical chemistry·2026
Same author

Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction.

American journal of human genetics·2025

Area of Science:

  • Molecular oncology
  • Epigenetics
  • Cancer biomarkers

Background:

  • Circulating tumor nucleic acids in blood reflect tumor biology.
  • Aberrant DNA methylation silences critical genes during tumor progression.
  • Hypermethylation and mRNA markers in blood show potential for cancer detection.

Purpose of the Study:

  • To explore the diagnostic and prognostic potential of circulating tumor DNA methylation and mRNA markers.
  • To evaluate the utility of these blood-based markers for cancer detection and monitoring.

Main Methods:

  • Analysis of circulating tumor DNA methylation patterns in blood.
  • Quantification of circulating tumor cell messenger RNAs (mRNAs) in patient blood samples.

Main Results:

  • Hypermethylation of multiple genes in blood is a promising cancer biomarker.
  • Circulating tumor cell mRNAs can be quantified for monitoring cancer progression and treatment response.

Conclusions:

  • Blood-based DNA methylation and mRNA markers offer new diagnostic and prognostic possibilities for various cancer types.
  • These molecular markers can aid in early cancer detection and patient management.

Related Experiment Videos